The evolving landscape of precision medicine in primary liver cancer
Authors:
Open Access
- 4 June 2019
- journal article
- editorial
- Published by Taylor & Francis in Hepatic Oncology
- Vol. 6 (2) , HEP12
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Imagestream detection and characterisation of circulating tumour cells – A liquid biopsy for hepatocellular carcinoma?Journal of Hepatology, 2016
- Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartmentJournal of Clinical Investigation, 2015
- Molecular Analysis for Therapy Choice: NCI MATCHSeminars in Oncology, 2014
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial DesignClinical Cancer Research, 2014
- Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytesJournal of Clinical Investigation, 2012
- RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasisNature, 2012
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerNew England Journal of Medicine, 2010
- Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysisGut, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre studyGut, 2004